Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
194 participants
OBSERVATIONAL
2020-05-05
2022-06-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The burden on global critical care has been considerable. As of 24th April there have been 8752 UK critical care admissions with services under considerable strain, and a mortality rate over 50%. Survivors of critical illness will require significant input.
This study will perform mixed methods to provide rich data on risk stratification and recovery from critical illness. Recovery from a novel disease requires documenting and the study reports physical and psychological changes following hospital discharge in survivors. In addition qualitative interviews are being conducted with patients who have survived and been discharged from critical care along with their relatives and treating professionals, to better understand their needs during recovery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
NCT04838106
French Single Centre Experience of Critically Ill Patients With Covid 19
NCT04354558
Infection Surveillance in Intensive Care Patients
NCT00197847
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180
Healthcare-associated Infections in Severe COVID-19 During 2020
NCT04819165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Relatives or friends and professionals involved in the care of these patients.
Exclusion Criteria
2. Patients with a negative test for SARS-CoV-2 or patients not tested due to absence of symptoms;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western Sussex Hospitals NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Luke Hodgson
Role: PRINCIPAL_INVESTIGATOR
Western Sussex Hospitals NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Luke Hodgson
Worthing, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20/YH/0157
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.